Biosimilars Market And its Growth prospect in the Near Future
On the basis of technology, the biosimilars market is categorized into five categories, such as monoclonal antibody (mAb), recombinant deoxyribonucleic acid (rDNA), bioassays, nuclear magnetic resonance (NMR), and electrophoresis. Biosimilars manufactured using mAb technology held the largest share, of 56%, in 2018. This technology is also expected to be the fastest growing category in the market, owing to large development of therapeutics with the help of this technology for various diseases such as cancer, immunological, and infectious diseases. Geographically, Europe held the largest share, of 47.7%, in the biosimilars market in 2018. This is attributed to flexible regulatory framework, growing geriatric population, and rising R&D investment by biopharmaceutical companies in the region. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/biosimilars-market
★
★
★
★
★
66 views • 6 slides
